Cetera Investment Advisers’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $54.7K | Sell |
31,814
-1,794
| -5% | -$3.09K | ﹤0.01% | 3960 |
|
|
2025
Q1 | $112K | Buy |
33,608
+7,814
| +30% | +$26K | ﹤0.01% | 3750 |
|
|
2024
Q4 | $191K | Sell |
25,794
-2,797
| -10% | -$20.7K | ﹤0.01% | 3437 |
|
|
2024
Q3 | $268K | Buy |
28,591
+4,255
| +17% | +$40K | ﹤0.01% | 3166 |
|
|
2024
Q2 | $195K | Buy |
24,336
+7,310
| +43% | +$58.6K | ﹤0.01% | 3368 |
|
|
2024
Q1 | $252K | Buy |
17,026
+6,564
| +63% | +$97.3K | ﹤0.01% | 3184 |
|
|
2023
Q4 | $85.1K | Buy |
+10,462
| New | +$85.1K | ﹤0.01% | 2153 |
|